Eckert & Ziegler
Telephone: +49-30-94 10 84 – 0
Telefax: +49-30-94 10 84 – 470
Board of Directors:
Dr. Andreas Eckert
Dr. André Heß
Commercial register number: HRB 97514 B, Berlin, Amtsgericht Charlottenburg
Value added tax identification number: DE 814 826 257
Design, concept and programming: Christian Höpfner Informatics
This website is operated by Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler), based in Berlin, Germany and is geared towards the international user.
The information on this website is general information about the Eckert & Ziegler Radiopharma Business division, but is no substitute for a commercial, medical or other type of consultation. In particular, the contents of this website should not form the basis of an investment/purchase decision.
The contents of this website are compiled and updated by Eckert & Ziegler to the best of its knowledge. However, Eckert & Ziegler does not accept any guarantee for the completeness and correctness of information at any time. You therefore use the contents at your own risk. No liability for the usage of the information is accepted.
Eckert & Ziegler accepts no guarantee that the contents of this website are correct worldwide or compatible with the applicable legal provisions at the place where the user is situated. Any legal claims or court proceedings associated with this website or its usage are solely subject to the laws of the Federal Republic of Germany.
By linking to third party websites, Eckert & Ziegler accepts no responsibility for the completeness, correctness and legality of the contents of these websites or for them continuing to be available. Eckert & Ziegler has no influence on the current and future format and contents of the third party websites linked to and does not make their contents its own. These third party websites are therefore solely subject to the liability of the relevant operator. However, at the time the relevant websites were first linked to, Eckert & Ziegler was convinced that they were free of contents contrary to the law. Where there are grounds to believe that contents contrary to the law are present, Eckert & Ziegler shall remove the links immediately.
Copyright and Trademarks
This website and these documents and illustrations provided here are protected by copyright. Duplication, processing, distribution and usage whatsoever outside the bounds of copyright need the permission of Eckert & Ziegler. Downloads and copies of contents of the website are only granted for non-commercial use, as long as the information is not altered in any way and all illustrations of the website are only used together with the accompanying text.
The trading names and the Eckert & Ziegler logo mentioned on this website are legally protected trademarks of the Eckert & Ziegler Group in Germany and other countries, where they are not made known as rights to third parties or are otherwise identifiable as such. The unauthorized usage of trademarks owned by the Eckert & Ziegler Group is expressly prohibited.
Storing and Processing Data
You can refuse the use of Google Analytics by clicking on the following link. An opt-out cookie will be set on the computer, which prevents the future collection of your data when visiting this website: https://tools.google.com/dlpage/gaoptout?hl=en or click Disable Google Analytics.
Further information concerning the terms and conditions of use and data privacy can be found at http://www.google.com/analytics/terms/gb.html or at https://www.google.de/intl/en_uk/policies/. Please note that on this website, Google Analytics code is supplemented by “anonymizeIp” to ensure an anonymized collection of IP addresses (so called IP-masking).
Usage of Personal Data
Usage of Contact Data for Advertising Purposes
The use and forwarding for commercial advertising of Eckert & Ziegler Group contact data given on this website is expressly refuted. The refutal does not apply where there is an ongoing commercial relationship with the Eckert & Ziegler Radiopharma segment at the time of sending the commercial advertising or where the Eckert & Ziegler Radiopharma segment has expressly permitted sending the commercial advertising.